X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/chordia-therapeutics-announces-interim-results-of-the-phase-1-clinical-trial-of-clk-inhibitor-ctx-712-at-the-2022-asco-annual-meeting-301562398.html